Literature DB >> 25042636

Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.

Giovanni Marfia1, Rolando Campanella, Stefania Elena Navone, Clara Di Vito, Elena Riccitelli, Loubna Abdel Hadi, Andrea Bornati, Gisele de Rezende, Paola Giussani, Cristina Tringali, Paola Viani, Paolo Rampini, Giulio Alessandri, Eugenio Parati, Laura Riboni.   

Abstract

Accumulating reports suggest that human glioblastoma contains glioma stem-like cells (GSCs) which act as key determinants driving tumor growth, angiogenesis, and contributing to therapeutic resistance. The proliferative signals involved in GSC proliferation and progression remain unclear. Using GSC lines derived from human glioblastoma specimens with different proliferative index and stemness marker expression, we assessed the hypothesis that sphingosine-1-phosphate (S1P) affects the proliferative and stemness properties of GSCs. The results of metabolic studies demonstrated that GSCs rapidly consume newly synthesized ceramide, and export S1P in the extracellular environment, both processes being enhanced in the cells exhibiting high proliferative index and stemness markers. Extracellular S1P levels reached nM concentrations in response to increased extracellular sphingosine. In addition, the presence of EGF and bFGF potentiated the constitutive capacity of GSCs to rapidly secrete newly synthesized S1P, suggesting that cooperation between S1P and these growth factors is of central importance in the maintenance and proliferation of GSCs. We also report for the first time that S1P is able to act as a proliferative and pro-stemness autocrine factor for GSCs, promoting both their cell cycle progression and stemness phenotypic profile. These results suggest for the first time that the GSC population is critically modulated by microenvironmental S1P, this bioactive lipid acting as an autocrine signal to maintain a pro-stemness environment and favoring GSC proliferation, survival and stem properties.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  CD133; ceramide; growth factors; sphingolipid metabolism; stem cell niche

Mesh:

Substances:

Year:  2014        PMID: 25042636     DOI: 10.1002/glia.22718

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  18 in total

Review 1.  Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.

Authors:  Christina Voelkel-Johnson; James S Norris; Shai White-Gilbertson
Journal:  Adv Cancer Res       Date:  2018-06-20       Impact factor: 6.242

Review 2.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

3.  Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.

Authors:  Justin Sharim; Randy Tashjian; Nima Golzy; Nader Pouratian
Journal:  J Clin Neurosci       Date:  2016-03-09       Impact factor: 1.961

Review 4.  Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review.

Authors:  Shailaja Mahajan-Thakur; Sandra Bien-Möller; Sascha Marx; Henry Schroeder; Bernhard H Rauch
Journal:  Int J Mol Sci       Date:  2017-11-17       Impact factor: 5.923

Review 5.  New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.

Authors:  Jan Korbecki; Izabela Gutowska; Ireneusz Kojder; Dariusz Jeżewski; Marta Goschorska; Agnieszka Łukomska; Anna Lubkowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Oncotarget       Date:  2018-01-09

6.  SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.

Authors:  A Mitrofanova; S K Mallela; G M Ducasa; T H Yoo; E Rosenfeld-Gur; I D Zelnik; J Molina; J Varona Santos; M Ge; A Sloan; J J Kim; C Pedigo; J Bryn; I Volosenco; C Faul; Y H Zeidan; C Garcia Hernandez; A J Mendez; I Leibiger; G W Burke; A H Futerman; L Barisoni; Y Ishimoto; R Inagi; S Merscher; A Fornoni
Journal:  Nat Commun       Date:  2019-06-19       Impact factor: 14.919

Review 7.  Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases.

Authors:  Sara Grassi; Laura Mauri; Simona Prioni; Livia Cabitta; Sandro Sonnino; Alessandro Prinetti; Paola Giussani
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

Review 8.  Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma.

Authors:  Rajeev Nema; Supriya Vishwakarma; Rahul Agarwal; Rajendra Kumar Panday; Ashok Kumar
Journal:  Onco Targets Ther       Date:  2016-05-31       Impact factor: 4.147

9.  Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme.

Authors:  Sandra Bien-Möller; Sandra Lange; Tobias Holm; Andreas Böhm; Heiko Paland; Johannes Küpper; Susann Herzog; Kerstin Weitmann; Christoph Havemann; Silke Vogelgesang; Sascha Marx; Wolfgang Hoffmann; Henry W S Schroeder; Bernhard H Rauch
Journal:  Oncotarget       Date:  2016-03-15

10.  MGMT-Methylated Alleles Are Distributed Heterogeneously Within Glioma Samples Irrespective of IDH Status and Chromosome 10q Deletion.

Authors:  Laura Fontana; Silvia Tabano; Eleonora Bonaparte; Giovanni Marfia; Chiara Pesenti; Rossella Falcone; Claudia Augello; Nicole Carlessi; Rosamaria Silipigni; Silvana Guerneri; Rolando Campanella; Manuela Caroli; Silvia Sirchia; Silvano Bosari; Monica Miozzo
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-26       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.